Tornado touches down near Chicago's O'Hare airport amid extreme weather nationwide

1:48StormcloudspassoverChicago,Illinois,onJuly12,2023,astheNationalWeatherServiceissuedmultipletorna EssayauthorSarahMcCarthycuddleswithherdaughterMolly.CourtesySarahMcCarthyTheventilatoralarmwokemeat3




comprehensive

author：comprehensive    Page View：92622
Judge's gavel
Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

advertisement

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In
Previous article： The Readout: Amylyx, Alumis, and Lundbeck drug updates
Next article： George Santos makes 1st court appearance after pleading not guilty to 13 counts